Latest Announcements

Alzheimer's Disease

Prana Alzheimer’s disease Development Plan Update

Prana Biotechnology (ASX:PBT) has today provided an update on its clinical development program for Alzheimer’s disease.


Huntington's Disease, Investor Announcement

Video Interview: Professor Ira Shoulson

Professor Ira Shoulson comments on joining Prana Biotechnology’s Board of Directors.


Movement disorders expert Professor Ira Shoulson joins Prana Biotechnology's Board of Directors

Email Newsletter

Receive regular updates from Prana Biotechnology by entering your details below and clicking "Subscribe"